Early buyers will receive 10% customization on this report.
By product, the western blotting market is categorized into consumables and instruments. The consumables segment is expected to command the largest share of the global western blotting market, by product in 2016. This is attributed to factors such as increasing use of western blotting in research & diagnosis and rising incidence of diseases that require western blotting for diagnosis.
The western blotting instruments are further segmented into gel electrophoresis instruments, blotting systems, and imagers. The blotting systems segment is expected to account for the largest share of the western blotting instruments market, by type in 2016. The semi-dry blotting systems are expected to command the largest share of blotting systems market, by type and are likely to grow at the highest CAGR during the forecast period. The largest share of this segment is attributed to high sensitivity, low run time, and high efficiency.
On the basis of application, the global western blotting market is segmented biomedical & biochemical research, disease diagnostics, agriculture and others (biologics and quality control). The biomedical & biochemical research segment is expected to account for the largest share of the global western blotting market, by application in 2016. This can be attributed to the rising government spending in proteomics research, and increased R&D spending by pharmaceutical & biotechnology companies in drug discovery and development.
However, the disease diagnostics segment is projected to grow at the highest CAGR from 2016 to 2021. This can be attributed rising prevalence and incidences of HIV, HSV, HBV, and Lyme disease, among others.
On the basis of end user, the western blotting market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, diagnostic centers and others (CROs, food & beverage companies and forensic laboratories). In 2016, the academic & research institutes segment is expected to command the largest share of the global western blotting market, by end user.
This can be attributed to the increasing research activities in the academic institutes backed by government funding and HIV initiatives by various governments across the globe. However, the disease diagnostics segment is projected to grow at the highest CAGR from 2016 to 2021.
On the basis of region, the global market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is poised to account for the largest share of the western blotting market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period. Factors such as development of bioclusters in China and India, growing pharmaceutical and biotechnology sector in Japan, growing funding for agriculture research in India, increasing government interest in biomedical & biotechnology industry in China, increasing diagnosis and related funding for HIV in Australia, and growing prevalence of HSV in south east Asia are expected to propel the growth of the western blotting market in the Asia-Pacific region.
Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.S.), Advansta, Inc. (U.S.), LI-COR Biosciences (U.S.), PerkinElmer, Inc. (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), and Cell Signaling Technology, Inc. (U.S.) are some of the key players in the western blotting market worldwide.
About MarketsandMarkets:
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
